Barbara J Harrington
CIK 1216303 · View on SEC EDGAR ↗
First SEC filing: Feb. 14, 2013 · Latest: Feb. 21, 2014
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2018 | BUSEP | P | 83 | — | — | 2,105 Indirect | +4.10% | Acquired | (price as of 2026-08-21) |
| March 30, 2018 | BUSEP | P | 249 | — | — | 2,022 Indirect | +14.04% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2017 | BUSEP | P | 68 | — | — | 1,773 Indirect | +3.99% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2017 | BUSEP | P | 67 | — | — | 1,696 Indirect | +4.11% | Acquired | (price as of 2026-08-21) |
| June 30, 2017 | BUSEP | P | 68 | — | — | 1,629 Indirect | +4.36% | Acquired | (price as of 2026-08-21) |
| March 31, 2017 | BUSEP | P | 218 | — | — | 1,551 Indirect | +16.35% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2016 | BUSEP | P | 76 | — | — | 1,326 Indirect | +6.08% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2016 | BUSEP | P | 90 | — | — | 1,250 Indirect | +7.76% | Acquired | (price as of 2026-08-21) |
| June 30, 2016 | BUSEP | P | 85 | — | — | 1,151 Indirect | +7.97% | Acquired | (price as of 2026-08-21) |
| March 31, 2016 | BUSEP | P | 295 | — | — | 1,066 Indirect | +38.26% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2015 | BUSEP | P | 98 | — | — | 771 Indirect | +14.56% | Acquired | (price as of 2026-08-21) |
| Sept. 30, 2015 | BUSEP | P | 96 | — | — | 673 Indirect | +16.64% | Acquired | (price as of 2026-08-21) |
| June 30, 2015 | BUSEP | P | 262 | — | — | 1,716 Indirect | +18.02% | Acquired | (price as of 2026-08-21) |
| March 31, 2015 | BUSEP | P | 857 | — | — | 1,455 Indirect | +143.31% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2014 | BUSEP | P | 252 | — | — | 598 Indirect | +72.83% | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| May 16, 2006 | BUSEP | Stock Option | Common Stock (6,000) | $20.16 | Dec. 15, 2011 | 6,000 | Acquired |
| Sept. 14, 2004 | BUSEP | Common | Common (8,000) | $19.59 | Sept. 14, 2009 | 8,000 | Acquired |
| Dec. 1, 2003 | BUSEP | Employee Stock Option | Common (3,000) | $16.25 | Sept. 30, 2004 | 3,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2010 | $206,923 | — | $50,000 | — | — | $1,169 | $22,851 | $280,943 |
| 2009 | $200,000 | — | — | — | — | $2,025 | $28,611 | $230,636 |
| 2008 | $200,000 | — | — | — | — | $35 | $25,726 | $225,761 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.